+86 137 2013 4139
+86 137 2013 4139
| CAS: | 923978-27-2 | Cat No: | JKN03422 | Purity: | 98% |
Note: All products of the company are for scientific research only, and do not provide products and services for any individual
Product Description
| CAS | 923978-27-2 | Cat No | JKN03422 | |
| Name | Elafibranor | |||
| Synonyms | Elafibranor | |||
| Smiles | CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)/C=C/C(=O)C2=CC=C(C=C2)SC | |||
| Chemical Name | 2-[2,6-dimethyl-4-[(E)-3-(4-methylsulfanylphenyl)-3-oxoprop-1-enyl]phenoxy]-2-methylpropanoic acid | |||
| Formula | C22H24O4S | MWt | 384.5 | |
| Purity | 98% | Storage | Store at 4--8℃ | |
| Description | Elafibranor is a dual peroxisome proliferator-activated receptor (PPAR) α and β/δ agonist that works to inhibit bile acid synthesis. On June 10, 2024, elafibranor was granted accelerated approval by the FDA for the treatment of primary biliary cholangitis (PBC). The drug was also approved by the EMA on September 23, 2024. | |||
Product Documents
Menu
Contact Us
Tel: +86 137 2013 4139
E-mail: orders@jknbiochem.com
Add.:Room 2120, Office Building 2, No.1 Baisha Fifth Road, Hongshan District, Wuhan City, Hubei Province, China
Get In Touch
Get In Touch
